SB208 Increases Daily Nail Growth Rate over Four Weeks of Treatment
17 mai 2018 08h05 HE
|
Novan, Inc.
MORRISVILLE, N.C., May 17, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that data from the Company’s onychomycosis development program with SB208 gel...
Novan Reports Positive Topline Results with SB208 in Phase 2 Trial
12 avr. 2017 06h06 HE
|
Novan, Inc.
MORRISVILLE, N.C., April 12, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced positive topline results from the Company’s Phase 2 clinical trial with...